China Animal Husbandry subsidiary reports narrower half-year loss as revenue falls

Zhongpu Bio-pharmaceutical Co., Ltd., a subsidiary of China Animal Husbandry Industry Co., Ltd., reported a net loss of CNY 18,236,968.72 for the six months ended June 30, 2025. This compares with a net loss of CNY 26,207,380.41 for the full year 2024. Total operating revenue for the first half of 2025 was CNY 18,853,368.72, down from CNY 37,005,675.46 in 2024.

The company's total assets as of June 30, 2025, were CNY 330,103,314.34, a decrease from CNY 356,408,116.47 at the end of 2024. Total liabilities also decreased to CNY 40,963,685.25 from CNY 49,531,136.38.

The audit report, prepared by Pan-China Certified Public Accountants, highlights that these financial statements were prepared specifically due to the exit of CITIC Agricultural Science and Technology Co., Ltd. from its entire equity stake in Zhongpu Bio-pharmaceutical Co., Ltd. This preparation also serves China Animal Husbandry Industry Co., Ltd.'s disclosure obligations and the financial statements are not intended for other uses or parties beyond company management.

Cash generated from operating activities amounted to CNY 3,250,336.65 in the first half of 2025, compared to CNY 7,682,752.61 in 2024. The company's total owner's equity as of June 30, 2025, was CNY 289,139,629.09, down from CNY 306,876,980.09 at the end of 2024.